Reich Kristian's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Jul 23, 2026
- Accession no.
- 0001213900-26-080869
- Filed
- Jul 23, 2026, 4:05 PM ET
- Trade date
- Jul 21-22, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.05M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reich KristianCIK 0001920553 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −50,000 | $20.02 | −$1,001,000 | 2,714,746 | Indirect | |
| Jul 22, 2026 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −2,448 | $20.00 | −$48,960 | 2,712,298 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.